US Stock MarketDetailed Quotes

NMTC NeuroOne Medical

Watchlist
  • 1.0400
  • +0.0200+1.96%
Close Jan 22 16:00 ET
32.09MMarket Cap-2.26P/E (TTM)

NeuroOne Medical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Sep 30, 2024
(Q4)Sep 30, 2024
(Q3)Jun 30, 2024
(Q2)Mar 31, 2024
(Q1)Dec 31, 2023
(FY)Sep 30, 2023
(Q4)Sep 30, 2023
(Q3)Jun 30, 2023
(Q2)Mar 31, 2023
(Q1)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
14.55%-11.01M
8.13%-2.67M
19.72%-2.36M
38.75%-2.18M
-9.08%-3.81M
-71.38%-12.89M
-385.20%-2.9M
-11.52%-2.94M
-10.24%-3.55M
-30.35%-3.49M
Net income from continuing operations
-3.87%-12.32M
-6.87%-3.35M
20.22%-2.77M
18.95%-2.86M
-93.04%-3.34M
-18.60%-11.86M
-128.12%-3.14M
-25.69%-3.47M
-15.20%-3.52M
38.28%-1.73M
Operating gains losses
----
----
----
----
----
--32.14K
----
----
----
----
Depreciation and amortization
23.85%246.79K
2.59%64.13K
10.80%63.11K
38.69%60.9K
63.44%58.66K
67.99%199.27K
87.03%62.51K
80.78%56.96K
53.90%43.91K
42.64%35.89K
Other non cash items
509.67%669.61K
1,962.63%583K
2.15%28.28K
8.70%29.47K
7.80%28.86K
-48.23%109.83K
-78.61%28.27K
2.09%27.68K
1.66%27.11K
2.05%26.77K
Change In working capital
60.69%-954.61K
-87.68%-303.79K
-115.04%-22.87K
173.38%232.7K
59.05%-860.65K
-300.11%-2.43M
-108.17%-161.87K
179.58%152.04K
29.75%-317.12K
-1,566.20%-2.1M
-Change in receivables
-631.44%-176.64K
--233.92K
-32.19%145.09K
89.68%-12.24K
-775.29%-543.4K
120.13%33.24K
--0
484.82%213.95K
-892.25%-118.63K
-361.86%-62.08K
-Change in inventory
11.12%-908.47K
-300.52%-841.72K
-40.77%-481.76K
209.69%296.98K
159.31%118.03K
-68.60%-1.02M
16.02%-210.16K
-47.27%-342.22K
-3,854.20%-270.75K
-52.12%-199.02K
-Change in prepaid assets
43.71%47.29K
186.37%45.02K
-8.03%146.3K
0.80%-147.81K
-94.96%3.78K
122.61%32.9K
-66,719.23%-52.12K
758.57%159.08K
16.12%-149K
449.11%74.95K
-Change in payables and accrued expense
105.65%83.21K
157.94%259K
38.16%167.5K
107.76%95.76K
4.60%-439.06K
-175.50%-1.47M
-95.57%100.41K
978.75%121.23K
-348.00%-1.23M
-1,650.96%-460.22K
-Change in other working capital
----
----
----
----
----
----
----
----
----
-22,730.06%-1.46M
Cash from discontinued investing activities
Operating cash flow
14.55%-11.01M
8.13%-2.67M
19.72%-2.36M
38.75%-2.18M
-9.08%-3.81M
-71.38%-12.89M
-385.20%-2.9M
-11.52%-2.94M
-10.24%-3.55M
-30.35%-3.49M
Investing cash flow
Cash flow from continuing investing activities
-104.54%-120.2K
26.37%-36.91K
-101.72%-14.8K
-101.72%-31.36K
-346.41%-37.13K
181.67%2.65M
98.35%-50.12K
1,687.03%860.71K
2,054.91%1.82M
124.51%15.07K
Net PPE purchase and sale
68.09%-120.2K
26.37%-36.91K
89.37%-14.8K
82.15%-31.36K
-222.54%-37.13K
-36.84%-376.62K
24.27%-50.12K
-156.83%-139.29K
-88.27%-175.69K
81.28%-11.51K
Net investment purchase and sale
--0
--0
--0
--0
--0
201.92%3.03M
--0
--1M
--2M
--26.58K
Cash from discontinued investing activities
Investing cash flow
-104.54%-120.2K
26.37%-36.91K
-101.72%-14.8K
-101.72%-31.36K
-346.41%-37.13K
181.67%2.65M
98.35%-50.12K
1,687.03%860.71K
2,054.91%1.82M
124.51%15.07K
Financing cash flow
Cash flow from continuing financing activities
-1.75%7.27M
-51.00%2.54M
-0.02%1.56M
196.12%1.96M
7,768.90%1.21M
-38.46%7.4M
5.19M
1.56M
205,677.95%661.96K
-100.13%-15.71K
Net common stock issuance
-31.66%5.79M
-86.28%826.95K
1.52%1.64M
151.07%2.08M
--1.24M
-36.55%8.47M
--6.03M
--1.61M
--829.61K
--0
Proceeds from stock option exercised by employees
--1.81M
----
----
----
----
--0
----
----
----
----
Net other financing activities
68.93%-332.92K
88.49%-96.32K
-48.33%-76.19K
26.81%-122.71K
-139.92%-37.7K
19.26%-1.07M
---836.94K
---51.37K
-51,963.98%-167.65K
98.82%-15.71K
Cash from discontinued financing activities
Financing cash flow
-1.75%7.27M
-51.00%2.54M
-0.02%1.56M
196.12%1.96M
7,768.90%1.21M
-38.46%7.4M
--5.19M
--1.56M
205,677.95%661.96K
-100.13%-15.71K
Net cash flow
Beginning cash position
-34.78%5.32M
-47.46%1.62M
-32.41%2.43M
-42.56%2.68M
-34.78%5.32M
18.24%8.16M
-69.71%3.08M
-72.01%3.6M
-71.16%4.67M
18.24%8.16M
Current changes in cash
-36.11%-3.86M
-107.14%-159.94K
-57.06%-814.68K
76.88%-246.33K
24.37%-2.64M
-325.41%-2.84M
210.96%2.24M
80.72%-518.71K
67.87%-1.07M
-137.63%-3.49M
End cash Position
-72.57%1.46M
-72.57%1.46M
-47.46%1.62M
-32.41%2.43M
-42.56%2.68M
-34.78%5.32M
-34.78%5.32M
-69.71%3.08M
-72.01%3.6M
-71.16%4.67M
Free cash flow
16.12%-11.13M
8.67%-2.7M
22.87%-2.38M
40.80%-2.21M
-9.78%-3.85M
-70.26%-13.27M
-411.09%-2.96M
-14.44%-3.08M
-12.44%-3.73M
-27.85%-3.5M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Sep 30, 2024(Q4)Sep 30, 2024(Q3)Jun 30, 2024(Q2)Mar 31, 2024(Q1)Dec 31, 2023(FY)Sep 30, 2023(Q4)Sep 30, 2023(Q3)Jun 30, 2023(Q2)Mar 31, 2023(Q1)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 14.55%-11.01M8.13%-2.67M19.72%-2.36M38.75%-2.18M-9.08%-3.81M-71.38%-12.89M-385.20%-2.9M-11.52%-2.94M-10.24%-3.55M-30.35%-3.49M
Net income from continuing operations -3.87%-12.32M-6.87%-3.35M20.22%-2.77M18.95%-2.86M-93.04%-3.34M-18.60%-11.86M-128.12%-3.14M-25.69%-3.47M-15.20%-3.52M38.28%-1.73M
Operating gains losses ----------------------32.14K----------------
Depreciation and amortization 23.85%246.79K2.59%64.13K10.80%63.11K38.69%60.9K63.44%58.66K67.99%199.27K87.03%62.51K80.78%56.96K53.90%43.91K42.64%35.89K
Other non cash items 509.67%669.61K1,962.63%583K2.15%28.28K8.70%29.47K7.80%28.86K-48.23%109.83K-78.61%28.27K2.09%27.68K1.66%27.11K2.05%26.77K
Change In working capital 60.69%-954.61K-87.68%-303.79K-115.04%-22.87K173.38%232.7K59.05%-860.65K-300.11%-2.43M-108.17%-161.87K179.58%152.04K29.75%-317.12K-1,566.20%-2.1M
-Change in receivables -631.44%-176.64K--233.92K-32.19%145.09K89.68%-12.24K-775.29%-543.4K120.13%33.24K--0484.82%213.95K-892.25%-118.63K-361.86%-62.08K
-Change in inventory 11.12%-908.47K-300.52%-841.72K-40.77%-481.76K209.69%296.98K159.31%118.03K-68.60%-1.02M16.02%-210.16K-47.27%-342.22K-3,854.20%-270.75K-52.12%-199.02K
-Change in prepaid assets 43.71%47.29K186.37%45.02K-8.03%146.3K0.80%-147.81K-94.96%3.78K122.61%32.9K-66,719.23%-52.12K758.57%159.08K16.12%-149K449.11%74.95K
-Change in payables and accrued expense 105.65%83.21K157.94%259K38.16%167.5K107.76%95.76K4.60%-439.06K-175.50%-1.47M-95.57%100.41K978.75%121.23K-348.00%-1.23M-1,650.96%-460.22K
-Change in other working capital -------------------------------------22,730.06%-1.46M
Cash from discontinued investing activities
Operating cash flow 14.55%-11.01M8.13%-2.67M19.72%-2.36M38.75%-2.18M-9.08%-3.81M-71.38%-12.89M-385.20%-2.9M-11.52%-2.94M-10.24%-3.55M-30.35%-3.49M
Investing cash flow
Cash flow from continuing investing activities -104.54%-120.2K26.37%-36.91K-101.72%-14.8K-101.72%-31.36K-346.41%-37.13K181.67%2.65M98.35%-50.12K1,687.03%860.71K2,054.91%1.82M124.51%15.07K
Net PPE purchase and sale 68.09%-120.2K26.37%-36.91K89.37%-14.8K82.15%-31.36K-222.54%-37.13K-36.84%-376.62K24.27%-50.12K-156.83%-139.29K-88.27%-175.69K81.28%-11.51K
Net investment purchase and sale --0--0--0--0--0201.92%3.03M--0--1M--2M--26.58K
Cash from discontinued investing activities
Investing cash flow -104.54%-120.2K26.37%-36.91K-101.72%-14.8K-101.72%-31.36K-346.41%-37.13K181.67%2.65M98.35%-50.12K1,687.03%860.71K2,054.91%1.82M124.51%15.07K
Financing cash flow
Cash flow from continuing financing activities -1.75%7.27M-51.00%2.54M-0.02%1.56M196.12%1.96M7,768.90%1.21M-38.46%7.4M5.19M1.56M205,677.95%661.96K-100.13%-15.71K
Net common stock issuance -31.66%5.79M-86.28%826.95K1.52%1.64M151.07%2.08M--1.24M-36.55%8.47M--6.03M--1.61M--829.61K--0
Proceeds from stock option exercised by employees --1.81M------------------0----------------
Net other financing activities 68.93%-332.92K88.49%-96.32K-48.33%-76.19K26.81%-122.71K-139.92%-37.7K19.26%-1.07M---836.94K---51.37K-51,963.98%-167.65K98.82%-15.71K
Cash from discontinued financing activities
Financing cash flow -1.75%7.27M-51.00%2.54M-0.02%1.56M196.12%1.96M7,768.90%1.21M-38.46%7.4M--5.19M--1.56M205,677.95%661.96K-100.13%-15.71K
Net cash flow
Beginning cash position -34.78%5.32M-47.46%1.62M-32.41%2.43M-42.56%2.68M-34.78%5.32M18.24%8.16M-69.71%3.08M-72.01%3.6M-71.16%4.67M18.24%8.16M
Current changes in cash -36.11%-3.86M-107.14%-159.94K-57.06%-814.68K76.88%-246.33K24.37%-2.64M-325.41%-2.84M210.96%2.24M80.72%-518.71K67.87%-1.07M-137.63%-3.49M
End cash Position -72.57%1.46M-72.57%1.46M-47.46%1.62M-32.41%2.43M-42.56%2.68M-34.78%5.32M-34.78%5.32M-69.71%3.08M-72.01%3.6M-71.16%4.67M
Free cash flow 16.12%-11.13M8.67%-2.7M22.87%-2.38M40.80%-2.21M-9.78%-3.85M-70.26%-13.27M-411.09%-2.96M-14.44%-3.08M-12.44%-3.73M-27.85%-3.5M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------
Trending Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Netflix
NFLX
+9.69%
Oracle
ORCL
+6.75%
NVIDIA
NVDA
+4.43%
Microsoft
MSFT
+4.13%
Taiwan Semiconductor
TSM
+2.06%

Unlock the Full List